284 related articles for article (PubMed ID: 10716967)
1. Association of angiogenesis in lymph node metastases with outcome of breast cancer.
Guidi AJ; Berry DA; Broadwater G; Perloff M; Norton L; Barcos MP; Hayes DF
J Natl Cancer Inst; 2000 Mar; 92(6):486-92. PubMed ID: 10716967
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical study of angiogenesis of axillary lymph node metastasis in human breast carcinoma].
Wu L; Zhang W; Liu H
Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):433-5. PubMed ID: 11776619
[TBL] [Abstract][Full Text] [Related]
3. IV-DSA is a new diagnostic tool for axillary lymph node metastasis in breast cancer patients.
Watanabe O; Shimizu T; Imamura H; Kinoshita J; Utada Y; Okabe T; Kimura K; Hirano A; Aiba M; Ogawa K
J Surg Oncol; 2004 Aug; 87(2):75-9. PubMed ID: 15282699
[TBL] [Abstract][Full Text] [Related]
4. Association of angiogenesis and disease outcome in node-positive breast cancer patients treated with adjuvant cyclophosphamide, doxorubicin, and fluorouracil: a Cancer and Leukemia Group B correlative science study from protocols 8541/8869.
Guidi AJ; Berry DA; Broadwater G; Helmchen B; Bleiweiss IJ; Budman DR; Henderson IC; Norton L; Hayes DF
J Clin Oncol; 2002 Feb; 20(3):732-42. PubMed ID: 11821455
[TBL] [Abstract][Full Text] [Related]
5. Chalkley microvessel but not lymphatic vessel density correlates with axillary lymph node metastasis in primary breast cancers.
Kanngurn S; Thongsuksai P; Chewatanakornkul S
Asian Pac J Cancer Prev; 2013; 14(1):583-7. PubMed ID: 23534799
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
7. Microvessels that predict axillary lymph node metastases in patients with breast cancer.
Nathanson SD; Zarbo RJ; Wachna DL; Spence CA; Andrzejewski TA; Abrams J
Arch Surg; 2000 May; 135(5):586-93; discussion 593-4. PubMed ID: 10807285
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
9. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy.
Gasparini G; Barbareschi M; Boracchi P; Verderio P; Caffo O; Meli S; Dalla Palma P; Marubini E; Bevilacqua P
Cancer J Sci Am; 1995; 1(2):131-41. PubMed ID: 9166466
[TBL] [Abstract][Full Text] [Related]
10. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
[TBL] [Abstract][Full Text] [Related]
11. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
[TBL] [Abstract][Full Text] [Related]
12. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
[TBL] [Abstract][Full Text] [Related]
13. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
14. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
[TBL] [Abstract][Full Text] [Related]
15. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
16. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
17. Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma.
Wang W; Yuan P; Wang J; Ma F; Zhang P; Li Q; Xu B
Tumori; 2014; 100(6):600-4. PubMed ID: 25688492
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer.
Meric F; Mirza NQ; Buzdar AU; Hunt KK; Ames FC; Ross MI; Pollock RE; Newman LA; Feig BW; Strom EA; Buchholz TA; McNeese MD; Hortobagyi GN; Singletary SE
Ann Surg Oncol; 2000 Jul; 7(6):435-40. PubMed ID: 10894139
[TBL] [Abstract][Full Text] [Related]
19. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
[TBL] [Abstract][Full Text] [Related]
20. The analysis of CD34 antigen immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases.
Popiela TJ; Sikora J; Klimek M; Basta P; Niemiec T; Dobrogowski J; Kotlarz A; Rudnicka-Sosin L; Dutsch-Wicherek M
Neuro Endocrinol Lett; 2008 Aug; 29(4):443-6. PubMed ID: 18766141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
